Irinotecan news from FierceHealthcare
NewsMedicare overpaid for prescription drugs with generic versions
Medicare overpaid by millions for a cancer drug sold by Pfizer earlier this year because there was a delay in the agency updating its pricing formula, according to a new report from the HHS Office of Read more...
| Press ReleasesAPP Pharmaceuticals Issues a Nationwide Voluntary Recall of Irinotecan Hydrochloride InjectionSCHAUMBURG, Ill.--(BUSINESS WIRE)-- APP Pharmaceuticals, Inc., (APP) announced today that it has issued a voluntary recall of five lots of Irinotecan Hydrochloride Injection, which is used for Read more >> |
